Post
of 9,423
EOY Filing names New Markets for BIel
Korea and Taiwan.
"The Company’s sales for the year 2018 decreased $717,892 primarily because of a decline of UK sales by $450,000 and other international sales by $275,000. The other international sales decline is offset by deferred revenue (deposits) on hold pending regulatory clearances in the United Arab Republic, Korea, Taiwan, and Mundipharma in Southeast Asia."
The $536,000 sitting in Deferred Revenue is the deposit.
Korea..... 51 million people
Taiwan…… 23.5 million people
These are most likely via Mundipharma and are both countries with a growing middle class and disposable income.
Korea and Taiwan.
"The Company’s sales for the year 2018 decreased $717,892 primarily because of a decline of UK sales by $450,000 and other international sales by $275,000. The other international sales decline is offset by deferred revenue (deposits) on hold pending regulatory clearances in the United Arab Republic, Korea, Taiwan, and Mundipharma in Southeast Asia."
The $536,000 sitting in Deferred Revenue is the deposit.
Korea..... 51 million people
Taiwan…… 23.5 million people
These are most likely via Mundipharma and are both countries with a growing middle class and disposable income.